I HAD PARKINSON'S

We all suffer from sleep issues from time to time but if you are one of the 70 million people in the US alone, who suffer from sleep disorders, bedtime can be an anxiety inducing daily occurrence. CBD can be used for a variety of conditions that can impair your quality of sleep: Parkinson's related symptoms as: -Tremor - Dyskinesia - ON/OFF syndrome - Insomnia - Restless Leg Syndrome - Anxiety - Migraines - Arthritis - Muscle Pain - REM Sleep Behavior Disorder - General Pain How CBD Helps You SleepYour body is set up with an endocannabinoid system which provides much of the neural communication that affects your health, with endocannabinoid signaling playing a part in maintaining a restorative sleep cycle. CBD is an exogenous cannabinoid, although not produced naturally in the human body, it interacts with the endocannabinoid system.CBD has the ability to reduce Anxiety, Pain; the major trigger points to poor sleep and Insomnia. Unlike sleeping pills, CBD ha

Transcranial direct current stimulation (tDCS)  for Parkinson's - HOW TO TURN YOUR SMARTPHONE IN A tDCS DEVICE for a penny!  Since the rediscovery of transcranial direct current stimulation (tDCS) about 10 years ago, interest in tDCS has grown exponentially. A noninvasive stimulation technique that induces robust excitability changes within the stimulated cortex,tDCS is increasingly being used in proof-of-principle and stage IIa clinical trials in a wide range of neurological and psychiatric disorders. Alongside these clinical studies, detailed work has been performed to elucidate the mechanisms underlying the observed effects.  Mary Smith studies the potential of transcranial direct current stimulation (tDCS), brain stimulation technology, to help manage symptoms of Parkinson's Disease (PD). She explains how she and her team implement the technology, what positive results have been observed, what is anticipated for the future, and why her mother -- who has Y

Transcranial direct current stimulation (tDCS) for PD Nga Chau studies the potential of transcranial direct current stimulation (tDCS), brain stimulation technology, to help manage symptoms of Parkinson's Disease (PD). She explains how she and her team implement the technology, what positive results have been observed, what is anticipated for the future, and why her mother -- who has Young-Onset PD -- is vehemently opposed to participation.Nga studied neuroscience at Franklin and Marshall College. She now works in research at Johns Hopkins Hospital, in their neurology department. With a team of neurologists and engineers, they are studying transcranial direct current stimulation (tDCS), a form of brain stimulation technology, and its potential to treat symptoms of Parkinson's Disease. Nga's path and passion is largely influenced by her life experience caring for her mother, who suffers from Young-Onset Parkinson's. She is able to bring her academic and intimate

Inspirational Affirmations

NEW YEAR MEDITATION with Master Mingtong Gu

Top 10 Parkinson’s Stories of 2018 Parkinson’s News Today  provided you with daily coverage of important findings,  treatment  developments, and  clinical trials  related to Parkinson’s during 2018. We look forward to bringing more news to Parkinson’s patients, as well as their family members and caregivers, during 2019. Here are the Top 10 most-read articles of 2018, with a brief description of what made them interesting to the Parkinson’s community.   No. 10 – “ Phase 2 Trial Shows Nilotinib Potential to Modulate Dopamine in Parkinson’s “ Results of a Phase 2 trial ( NCT02954978 ) of  Novartis ’  nilotinib  in 75 patients with mid-stage Parkinson’s and mild  cognitive impairment  suggested the therapy increased production and metabolism of dopamine within one to four hours after a single  treatment . Also, low-dose nilotinib (150 mg and 200 mg) — marketed as  Tasigna  for certain types of leukemia — was associated with lower levels of an altered and